Atjaunināt sīkdatņu piekrišanu

E-grāmata: Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies

  • Formāts: 110 pages
  • Izdošanas datums: 29-Sep-2020
  • Izdevniecība: National Academies Press
  • Valoda: eng
  • ISBN-13: 9780309680943
  • Formāts - EPUB+DRM
  • Cena: 68,87 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: 110 pages
  • Izdošanas datums: 29-Sep-2020
  • Izdevniecība: National Academies Press
  • Valoda: eng
  • ISBN-13: 9780309680943

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

In December 2019, new cases of severe pneumonia were first detected in Wuhan, China, and the cause was determined to be a novel beta coronavirus related to the severe acute respiratory syndrome (SARS) coronavirus that emerged from a bat reservoir in 2002. Within six months, this new virusSARS coronavirus 2 (SARS-CoV-2)has spread worldwide, infecting at least 10 million people with an estimated 500,000 deaths. COVID-19, the disease caused by SARS-CoV-2, was declared a public health emergency of international concern on January 30, 2020 by the World Health Organization (WHO) and a pandemic on March 11, 2020. To date, there is no approved effective treatment or vaccine for COVID-19, and it continues to spread in many countries.





Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies lays out a framework to define and describe the data needs for a system to track and correlate viral genome sequences with clinical and epidemiological data. Such a system would help ensure the integration of data on viral evolution with detection, diagnostic, and countermeasure efforts. This report also explores data collection mechanisms to ensure a representative global sample set of all relevant extant sequences and considers challenges and opportunities for coordination across existing domestic, global, and regional data sources.

Table of Contents



Front Matter Summary 1 Introduction 2 Application of Genomic Epidemiology in Previous Infectious Disease Outbreaks 3 Current Genomic Epidemiology Efforts Related to SARS-CoV-2 4 Framework to Track and Correlate Viral Genome Sequences with Clinical and Epidemiological Data 5 Governance and Regulatory Considerations Appendix A: Committee Biosketches Appendix B: Public Committee Meeting Agendas
Acronyms And Abbreviations xiii
Summary 1(8)
1 Introduction
9(10)
Coronavirus Evolution and SARS-CoV-2
10(1)
The Power of Genomics in Understanding SARS-CoV-2
11(3)
Study Charge
14(2)
About This Report
16(1)
References
16(3)
2 Application Of Genomic Epidemiology In Previous Infectious Disease Outbreaks
19(14)
Previous Efforts to Integrate Analyses of Genomic, Clinical, and Epidemiological Data
19(6)
Best Practices and Keys to Future Success
25(2)
References
27(6)
3 Current Genomic Epidemiology Efforts Related To Sars-Cov-2
33(14)
Current SARS-CoV-2 Data Sources
33(8)
Current Efforts to Integrate SARS-CoV-2 Genome Sequence Data with Clinical and Epidemiological Data
41(2)
Concluding Remarks
43(1)
References
44(3)
4 Framework To Track And Correlate Viral Genome Sequences With Clinical And Epidemiological Data
47(22)
Considerations for Transmission, Evolution, and Clinical Disease
47(9)
Opportunities to Support Data Integration
56(1)
Infrastructure Needs
57(5)
Partnerships, Coordination, and Capacity Considerations
62(1)
Concluding Remarks
63(1)
References
64(5)
5 Governance And Regulatory Considerations
69(16)
Federalism Barriers and Opportunities
70(1)
International Sharing Barriers
70(2)
Perceived Versus Actual Domestic Legal Barriers
72(1)
The Health Insurance Portability and Accountability Act (HIPAA)
72(4)
Common Rule
76(4)
Governance
80(1)
Concluding Remarks
81(2)
References
83(2)
APPENDIXES
A COMMITTEE BIOSKETCHES
85(8)
B PUBLIC COMMITTEE MEETING AGENDAS
93